SCHEMBL3033752

SCHEMBL3033752

CNC(=O)c1ccc2cc(C(=O)NO)ccc2c1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.73
HDAC8 Q9BY41 3/20 0.73
HDAC2 Q92769 2/20 0.73
PLAU P00749 1/20 0.66
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PLK1 P53350 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631295 0.85 HDAC6 (1.00) HDAC6HDAC8HDAC2HPGDTSHR
SCHEMBL313250 0.85 PLAU (0.62) HDAC6HDAC8HDAC2PLAUHPGD
SCHEMBL30369626 0.84 PLAU (0.66) HDAC6HDAC8HDAC2PLAUPLK1
SCHEMBL761366 0.84 PLAU (0.66) HDAC6HDAC8HDAC2PLAUPLK1
SCHEMBL6640227 0.84 PLAU (0.66) HDAC6HDAC8HDAC2PLAUHPGD
SCHEMBL16811740 0.82 PLAU (0.64) HDAC6HDAC8HDAC2PLAUHPGD
SCHEMBL16302072 0.82 PLAU (0.64) HDAC6HDAC8HDAC2PLAUHPGD
SCHEMBL3028425 0.82 PLAU (0.74) HDAC6HDAC8HDAC2PLAUHPGD
SCHEMBL31305702 0.82 HDAC1 (0.71) HDAC6HDAC8HDAC2HDAC1HDAC3
SCHEMBL6010034 0.82 HDAC1 (0.71) HDAC6HDAC8HDAC2HDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 HDAC6 31/4885HDAC8 7/4885HDAC2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.